Android app on Google Play

Keryx Biopharma (KERX) Slumps Following Dilutive Stock Offering

January 29, 2013 4:31 PM EST Send to a Friend
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) shares are dipping in after-hours trading Tuesday after announcing that it commenced a $55 million common stock offering.

Striking while the iron is hot, Keryx shares are up 143 percent since the close last Friday on stronger Zernex results.




You May Also Be Interested In


Related Categories

Equity Offerings, Trader Talk

Add Your Comment